Development of equations to predict the influence of floor space on average daily gain, average daily feed intake and gain : feed ratio of finishing pigs.

Floor space allowance for pigs has substantial effects on pig growth and welfare. Data from 30 papers examining the influence of floor space allowance on the growth of finishing pigs was used in a meta-analysis to develop alternative prediction equations for average daily gain (ADG), average daily feed intake (ADFI) and gain : feed ratio (G : F). Treatment means were compiled in a database that contained 30 papers for ADG and 28 papers for ADFI and G : F. The predictor variables evaluated were floor space (m2/pig), k (floor space/final BW0.67), Initial BW, Final BW, feed space (pigs per feeder hole), water space (pigs per waterer), group size (pigs per pen), gender, floor type and study length (d). Multivariable general linear mixed model regression equations were used. Floor space treatments within each experiment were the observational and experimental unit. The optimum equations to predict ADG, ADFI and G : F were: ADG, g=337.57+(16 468×k)-(237 350×k 2)-(3.1209×initial BW (kg))+(2.569×final BW (kg))+(71.6918×k×initial BW (kg)); ADFI, g=833.41+(24 785×k)-(388 998×k 2)-(3.0027×initial BW (kg))+(11.246×final BW (kg))+(187.61×k×initial BW (kg)); G : F=predicted ADG/predicted ADFI. Overall, the meta-analysis indicates that BW is an important predictor of ADG and ADFI even after computing the constant coefficient k, which utilizes final BW in its calculation. This suggests including initial and final BW improves the prediction over using k as a predictor alone. In addition, the analysis also indicated that G : F of finishing pigs is influenced by floor space allowance, whereas individual studies have concluded variable results.

Evaluating the removal of pigs from a group and subsequent floor space allowance on the growth performance of heavy-weight finishing pigs.

A total of 1,092 finishing pigs (initially 36.3 kg) were used in a 117-d study to evaluate the impact of initial floor space allowance and removal strategy on the growth of pigs up to 140 kg BW. There were 4 experimental treatments with 14 pens per treatment. The first treatment provided 0.91 m per pig (15 pigs/pen). The other 3 treatments initially provided 0.65 m per pig (21 pigs/pen) with 3 different removal strategies. The second treatment (2:2:2) removed the 2 heaviest pigs from pens on d 64, 76, and 95 when floor space allowance was predicted to be limiting. Treatment 3 (2:4) removed the 2 heaviest pigs on d 76 and the 4 heaviest pigs on d 105. Treatment 4 (6) removed the heaviest 6 pigs on d 105. All pigs remaining in pens after removals were fed to d 117. Overall (d 0 to 117), pigs initially provided 0.91 m of floor space had increased ( < 0.05) ADG compared to pigs in pens on the 2:4 or 6 removal strategy, but ADG was not different compared with pigs on the 2:2:2 removal strategy. Total BW gain per pen was greater ( < 0.05) for pens initially stocked at 0.65 m compared to pens initially stocked at 0.91 m. Feed usage per pen was less ( < 0.05) for pens initially stocked at 0.91 m compared to pens initially providing 0.65 m of floor space and on removal strategies; however, feed usage per pig was greater ( < 0.05) for pigs initially stocked at 0.91 m compared to pigs initially stocked at 0.65 m and on removal strategies. Feed usage, on a pig or pen basis, was less ( < 0.05) for pigs on the 2:2:2 removal strategy compared to pigs on the 2:4 or the 6 removal strategy. Income over feed and facility cost (IOFFC) was less ( < 0.05) for pigs initially provided 0.91 m compared to pigs initially provided 0.65 m and on removal strategies. Also, IOFFC was less ( < 0.05) for pigs on the 2:2:2 compared to the 2:4 and 6 removal strategies. In conclusion, increasing the floor space allowance or the time points at which pigs are removed from the pen improved the growth of pigs remaining in the pen; however, IOFFC may be reduced because fewer pigs are marketed from each pen (pigs stocked at 0.91 m throughout the study) or from reducing total weight produced (2:2:2 removal strategy).

Evaluating the impact of maternal vitamin D supplementation: I. Sow performance, serum vitamin metabolites, and neonatal muscle characteristics.

In Exp. 1, 56 gestating sows (PIC 1050; 35 d postinsemination) were used in a 30-d trial to determine serum 25(OH)D response to increasing concentrations of dietary vitamin D. Sows were randomly allotted to 1 of 7 dietary D treatments (200, 800, 1,600, 3,200, 6,400, 12,800, or 25,600 IU of added D per kilogram of complete diet) with 8 sows per treatment. Increasing D increased (quadratic; < 0.001) serum 25(OH)D with the response depicted by the prediction equation: serum 25(OH)D, ng/mL = 35.1746 + (0.002353 × dietary D, IU/d) - (0.0000000156 × dietary D, IU/d). In Exp. 2, 112 sows and their litters were used to determine the effects of dietary vitamin D regimen on sow performance, subsequent preweaning pig performance, neonatal bone and muscle characteristics, and serum vitamin metabolites. Sows were allotted to 1 of 4 dietary treatments 3 to 5 d following breeding: 800, 2,000, or 9,600 IU of D per kilogram of the diet or 50 µg of 25(OH)D (2,000 IU of D equivalent from Hy-D, DSM Nutritional Products, Parsippany, NJ) per kilogram of diet. There were 25 to 27 sows per treatment. Increasing dietary D increased (linear, = 0.001) serum 25(OH)D of sows on d 100 of gestation, at farrowing, and at weaning. Increasing D in sow diets increased piglet serum 25(OH)D at birth (linear, = 0.001) and weaning (quadratic, = 0.033). Sows fed 50 µg of 25(OH)D/kg had intermediate ( < 0.004) serum 25(OH)D concentrations on d 100 of gestation, at farrowing, and at weaning compared with sows fed 2,000 IU of D/kg and sows fed 9,600 IU of D/kg. Pigs from sows fed 50 µg of 25(OH)D/kg had greater serum 25(OH)D compared with pigs from sows fed 2,000 IU of D/kg, but at weaning, serum 25(OH)D concentrations were similar. Also, pigs from sows fed 9,600 IU of D/kg had greater ( = 0.011) serum 25(OH)D at birth and weaning compared with pigs from sows fed 50 µg of 25(OH)D/kg. Maternal performance, litter characteristics, neonatal bone ash content, and neonatal muscle fiber characteristics were largely unaffected by the dietary vitamin D treatments. Overall, D and 25(OH)D are both useful at increasing serum 25(OH)D concentrations, but more D (on an equivalent IU basis) is needed to achieve similar serum 25(OH)D responses compared with feeding 25(OH)D. Concentration of maternal vitamin D supplementation in lactation impacted milk transfer of the vitamin more so than the form of the vitamin, as evidence by the weaned pig serum 25(OH)D concentrations.

Evaluating the impact of maternal vitamin D supplementation on sow performance: II. Subsequent growth performance and carcass characteristics of growing pigs.

A of subsample of 448 growing pigs (PIC 327 × 1050) weaned from 52 sows fed varying dietary vitamin D regimens were used in a split-plot design to determine the effects of maternal and nursery dietary vitamin D on growth performance. Sows were previously administered diets containing vitamin D as vitamin D (800, 2,000, or 9,600 IU/kg) or as 25(OH)D (50 µg [or 2,000 IU vitamin D equivalent]/kg from HyD; DSM Nutritional Products, Parsippany, NJ). Once weaned, pigs were allotted to pens on the basis of previous maternal vitamin D treatment, and then pens were randomly assigned to 1 of 2 nursery vitamin D dietary regimens (2,000 IU of vitamin D/kg or 50 µg 25(OH)D/kg). Pigs remained on nursery vitamin D treatments for 35 d, and then they were provided common finishing diets until market (135 kg). Growing pig serum 25(OH)D suggested that maternal dietary vitamin D influenced ( < 0.001 at weaning) serum concentrations early after weaning, but nursery vitamin D regimen had a larger impact ( < 0.001) on d 17 and 35 postweaning. Overall growth performance was not influenced by nursery vitamin D dietary treatments. From d 0 to 35 in the nursery, pigs from sows fed increasing vitamin D had increased (quadratic, < 0.003) ADG and ADFI, but G:F was similar regardless of maternal vitamin D regimen. Also, pigs from sows fed 50 µg/kg of 25(OH)D had increased ( = 0.002) ADG compared with pigs weaned from sows fed 800 IU of vitamin D. Throughout finishing (d 35 postweaning until 135 kg), ADG was increased (quadratic, = 0.005) and G:F was improved (quadratic, = 0.049) with increasing maternal dietary vitamin D. Also, pigs from sows fed 50 µg/kg of 25(OH)D had increased ( = 0.002) ADG compared with pigs weaned from sows fed 800 IU of vitamin D. Carcass data were collected from a subsample population separate from that used for the growth performance portion of the study, and a total of 642 carcasses from progeny of sows fed the varying dietary vitamin D treatments were used. Live BW of pigs at marketing and HCW were heavier ( < 0.030) for pigs from sows previously fed 25(OH)D compared with pigs from sows fed 9,600 IU of vitamin D. Overall, pigs from sows fed 2,000 IU of vitamin D grew faster after weaning compared with pigs from sows fed 800 or 9,600 IU of vitamin D. Pigs from sows fed 25(OH)D hag greater ADG compared with pigs from sows fed 800 IU of vitamin D, and they had increased final BW and HCW compared with pigs from sows fed 9,600 IU of vitamin D.

Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert Panel.

The present position paper summarises the outcomes of an expert panel discussion held by hospital-based and office-based physicians with ample experience in the treatment of geriatric patients. The optimal approach to stroke prevention in geriatric patients with atrial fibrillation (AF) has not been adequately clarified. Despite their high risk of stroke and clear indication for anticoagulation according to established risk scores, in practice geriatric AF patients often are withheld treatment because of comorbidities and comedications, concerns about low treatment adherence or fear of bleeding events, in particular due to falls. The panel agreed that geriatric patients should receive oral anticoagulation as a rule, unless a comprehensive neurological and geriatric assessment (including clinical examination, gait tests and validated instruments such as Modified Rankin Scale, Mini-mental state examination or Timed Test of Money Counting) provides sound reasons for refraining from treatment. All patients with a history of falls should be thoroughly evaluated for further evaluation of the causes. Patients with CHADS2 score ≥ 2 should receive anticoagulation even if at high risk for falls. The novel oral anticoagulants (NOAC) facilitate management in the geriatric population with AF (no INR monitoring needed, easier bridging during interventions) and have, based on available data, an improved benefit-risk ratio compared to vitamin K antagonists. Drugs with predominantly non-renal elimination are safer in geriatric patients and should be preferred.

[Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel]. / Optimale Schlaganfallprävention bei geriatrischen Patienten mit Vorhofflimmern. Konsensbericht eines interdiszipIinären Expertengremiums.

BACKGROUND: The optimal approach to stroke prevention in geriatric patients with atrial fibrillation (AF) has not been adequately clarified. Despite their high risk of stroke and clear indication for anticoagulation according to established risk scores, in practice geriatric AF patients often are withheld treatment because of comorbidities and comedications, concerns about low treatment adherence or fear of bleeding events, in particular due to falls. METHOD: The present position paper summarises the outcomes of an expert panel discussion held by hospital-based and office-based physicians with ample experience in the treatment of geriatric patients. RESULTS AND CONCLUSIONS: The panel agreed that geriatric patients should receive oral anticoagulation as a rule, unless a comprehensive neurological and geriatric assessment (including clinical examination, gait tests and validated instruments such as Modified Rankin Scale, Mini-mental state examination or Timed Test of Money Counting) provides sound reasons for refraining from treatment AII patients with a history of falls should be thoroughly evaluated for further evaluation of the causes. Patients with CHADS2 score ≥ 2 should receive anticoagulation even if at high risk for falls. The novel oral anticoagulants (NOAC) facilitate management in the geriatric population with AF (no INR monitoring needed, easier bridging during interventions) and have an improved benefit-risk ratio compared to vitamin K antagonists. Drugs with predominantly non-renal elimination are safer in geriatric

The effects of sodium sulfate in the water of nursery pigs and the efficacy of nonnutritive feed additives to mitigate those effects.

Two experiments were conducted to investigate the effects of sodium sulfate water and the efficacy of nonnutritive feed additives in nursery pig diets. In Exp. 1, 320 barrows (5.4 ± 0.1 kg BW and 21 d of age) were allotted to 1 of 8 treatments for 24 d in a 2 × 4 factorial with 2 levels of sodium sulfate water (control or 3,000 mg sodium sulfate/L added), and 4 dietary zeolite (clinoptilolite) levels (0, 0.25, 0.50, or 1%). Fecal samples were collected on d 5, 9, 16, and 23; visually scored for consistency (1 = firm and 5 = watery); and analyzed for DM. No interactions of sodium sulfate × zeolite were observed for any response criteria. Overall (d 0 to 24), pigs drinking sodium sulfate water had decreased (P < 0.01) ADG, ADFI, and G:F compared with pigs drinking control water. Pigs drinking sodium sulfate water also had increased (P < 0.01) fecal scores and lower (P < 0.04) fecal DM on d 5, 9, and 16 compared with pigs drinking control water. Increasing dietary zeolite increased (linear; P < 0.05) ADG and ADFI but had no effect on G:F. In Exp. 2, 350 barrows (5.7 ± 0.1 kg BW and 21 d of age) were allotted to 1 of 10 treatments in a 2 × 5 factorial for 21 d with 2 levels of sodium sulfate water (control or 2,000 mg sodium sulfate/L added) and 5 dietary treatments (control, 1 or 2% zeolite, 1% humic acid substance [HA], and 1% humic and fulvic acid substance [HFB]). Fecal samples were collected on d 5, 8, 15, and 21; visually scored for consistency (1 = firm and 5 = watery); and analyzed for DM. Overall (d 0 to 21), a water source × diet interaction was observed for ADG and G:F because pigs fed the 1% HA had decreased (P < 0.01) ADG and G:F when drinking sodium sulfate water compared with other treatments but increased ADG and G:F when drinking control water. Pigs drinking sodium sulfate water had decreased (P < 0.01) ADG and G:F and tended (P < 0.08) to have decreased ADFI compared with pigs drinking control water. Pigs drinking sodium sulfate water had increased (P < 0.01) fecal scores and decreased (P < 0.01) fecal DM on d 5 and 8. In conclusion, water high in sodium sulfate concentrations decreased growth performance and increased fecal moisture in newly weaned pigs. Although zeolite improved growth performance in the first experiment, it did not influence growth in the second study. The nonnutritive feed additives used in both experiments were unsuccessful in ameliorating the increased osmotic diarrhea observed from high sodium sulfate water.

Effects of supplemental vitamin D3 on serum 25-hydroxycholecalciferol and growth of preweaning and nursery pigs.

Four experiments were conducted to investigate the effects of varying concentrations of supplemental vitamin D3 on pig growth, feed preference, serum 25-hydroxycholecalciferol [25(OH)D3] , and bone mineralization of nursing and weanling pigs. In Exp. 1, 270 pigs (1.71 ± 0.01 kg BW) were administered 1 of 3 oral vitamin D3 dosages (none, 40,000, or 80,000 IU vitamin D3) on d 1 or 2 of age. Increasing oral vitamin D3 increased serum 25(OH)D3 on d 10 and 20 (quadratic, P < 0.01) and d 30 (linear, P < 0.01). No differences were observed in ADG before weaning or for nursery ADG, ADFI, or G:F. Vitamin D3 concentration had no effect on bone ash concentration or bone histological traits evaluated on d 19 or 35. In Exp. 2, 398 barrows (initially 7 d of age) were used in a 2 × 2 split plot design to determine the influence of vitamin D3 before (none or 40,000 IU vitamin D3 in an oral dose) or after weaning (1,378 or 13,780 IU vitamin D3/kg in nursery diets from d 21 to 31 of age) in a 45-d trial. Before weaning (7 to 21 d of age), oral vitamin D3 dose did not influence growth but increased (P < 0.01) serum 25(OH)D3 at weaning (d 21) and tended (P = 0.08) to increase 25(OH)D3 on d 31. Increasing dietary vitamin D3 concentration from d 21 to 31 increased (P < 0.01) serum 25(OH)D3 on d 31. Neither the oral vitamin D3 dose nor nursery vitamin D3 supplements influenced nursery ADG, ADFI, or G:F. In Exp. 3, 864 pigs (initially 21 d of age) were allotted to 1 of 2 water solubilized vitamin D3 treatments (none or 16,516 IU/L vitamin D3 provided in the drinking water from d 0 to 10) in a 30-d study. Providing vitamin D3 increased serum 25(OH)D3 concentrations on d 10, 20, and 30; however, vitamin D3 supplementation did not affect overall (d 0 to 30) ADG, ADFI, or G:F. In Exp. 4, 72 pigs were used in a feed preference study consisting of 2 feed preference comparisons. Pigs did not differentiate diets containing either 1,378 or 13,780 IU vitamin D3/kg but consumed less (P < 0.01) of a diet containing 44,100 IU vitamin D3/kg compared with the diet containing 1,378 IU vitamin D3/kg. Overall, these studies demonstrate that supplementing vitamin D3 above basal concentrations used in these studies is effective at increasing circulating 25(OH)D3, but the supplement did not influence growth or bone mineralization. Also, concentrations of vitamin D3 of 44,100 IU/kg of the diet may negatively affect feed preference of nursery pigs.

An evaluation of the effects of added vitamin D3 in maternal diets on sow and pig performance.

A total of 84 sows (PIC 1050) and their litters were used to determine the effects of supplementing maternal diet with vitamin D3 on sow and pig performance, serum 25-hydroxyvitamin D3 (25(OH)D3), milk vitamin D3, neonatal bone mineralization, and neonatal tissue vitamin D3. After breeding, sows were randomly assigned to 1 of 3 dietary vitamin D3 treatments (1,500, 3,000, or 6,000 IU/kg of complete diets). Sows were bled on d 0 and 100 of gestation and at farrowing and weaning (d 21). Pig BW was recorded at birth and weaning, and serum was collected from 2 pigs/litter at birth, on d 10 and at weaning. A total of 54 pigs (18/treatment) were euthanized at birth and necropsied to sample bones and tissues. Sow and suckling pig performance and neonatal bone ash and bone density did not differ among maternal vitamin D3 treatments; however, sow 25(OH)D3 and milk vitamin D3 increased (linear, P < 0.01) with increasing maternal vitamin D3 supplementation. Piglet serum 25(OH)D3 increased (quadratic, P < 0.03) with increased maternal vitamin D3. Neonatal kidney vitamin D3 tended (quadratic, P = 0.08) to decrease with increasing maternal vitamin D3, but liver vitamin D3 tended (linear, P = 0.09) to increase with increasing maternal vitamin D3. At weaning, a subsample of 180 pigs (PIC 327 × 1050) were used in a 3 × 2 split plot design for 35 d to determine the effects of maternal vitamin D3 and 2 levels of dietary vitamin D3 (1,800 or 18,000 IU/kg) from d 0 to 10 postweaning on nursery growth and serum 25(OH)D3. Overall (d 0 to 35), nursery ADG and G:F were not affected by either concentration of vitamin D3, but ADFI tended (quadratic, P < 0.06) to decrease with increasing maternal vitamin D3 as pigs from sows fed 3,000 IU had lower ADFI compared with pigs from sows fed 1,500 or 6,000 IU/kg. Nursery pig serum 25(OH)D3 increased with increasing maternal vitamin D3 (weaning) on d 0 (linear, P < 0.01), and maternal × diet interactions (P < 0.01) were observed on d 10 and 21 because pigs from sows fed 1,500 IU had greater increases in serum 25(OH)D3 when fed 18,000 IU compared with pigs from sows fed 3,000 IU. In conclusion, sow and pig serum 25(OH)D3, milk vitamin D3, and neonatal tissue vitamin D3 can be increased by increasing maternal vitamin D3, and nursery pig 25(OH)D3 can be increased by increasing dietary vitamin D3; however, sow and pig performance and neonatal bone mineralization was not influenced by increasing vitamin D3 dietary levels.

Improving the health care of geriatric patients: management of urinary incontinence: a position paper.

A multidisciplinary German expert group met in 2012 to discuss the current status and prospects of health care of geriatric patients with urinary incontinence in Germany. The purpose of this position paper is to raise awareness among health care providers for the challenges associated with adequate management of urinary incontinence in frail elderly. The experts agree that a multidisciplinary collaboration is essential for the successful treatment of urinary incontinence symptoms which are often associated with loss of autonomy and social isolation. For most geriatric patients, usually the general practitioner is the first contact when seeking help. Hence, the general practitioner plays a crucial role in the coordination of diagnosis and treatment. The involved health care providers should have adequate education and training in their respective disciplines and should be networked allowing quick turnaround times. Non-pharmacological treatments (e.g. behavioural interventions) should have been tried before any pharmacotherapy is initiated. If pharmacological treatment of urinary incontinence involves the use of anticholinergic agents, cognitive performance should be monitored regularly. If indicated, anticholinergic agents with a documented efficacy and safety profile, explicitly assessed in the elderly population, should be preferred.

Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.

BACKGROUND: End-stage renal failure after successful liver transplantation (LTx) has been described in up to 5% of patients. Kidney transplantation (KTx) has been the treatment of choice in these cases. However, in recipients infected with hepatitis C virus (HCV), the augmentation of immunosuppression after KTx may result in an increased viral load. This, in turn, may adversely affect the liver allograft. METHOD: The present study retrospectively examined the outcome in 17 patients (3 females and 14 males, mean age 51.1+/-11.3 years) who received KTx after LTx. The mean interval from LTx to KTx was 57.6+/-32.1 months. The mean follow-up was 41.7+/-20.5 months after KTx, and 99.6+/-37.7 months after LTx. Sixteen of the 17 patients received tacrolimus-based immunosuppression at the time of KTx. RESULTS: During the follow-up period, one patient underwent combined liver and kidney retransplantation 3.7 years after KTx and 12.7 years after LTx. She subsequently died secondary to primary nonfunction. Four other patients died, two of lung cancer, one of pancreatitis/sepsis, and one of severe depression leading to noncompliance. A total of 29 episodes of biopsy-proven acute renal allograft rejection (1.7 episodes/ patient) were encountered and treated with steroids. Seven patients experienced a rise in liver function tests during the period of increased steroid dosage. Four patients received no treatment, and their liver function returned to baseline. The remaining three were treated with interferon. Overall 1- and 3-year actuarial patient and liver allograft survival was 88% and 71% (after renal transplantation); corresponding 1- and 3-year actuarial graft survival was 88% and 61%. Twelve patients are alive with normal liver function. One patient is on dialysis, because of renal allograft loss to noncompliance. CONCLUSION: In this series, LTx recipients with HCV infection were able to undergo KTx with a reasonable degree of success. KTx should be offered for end-stage renal failure after LTx, even in the presence of HCV infection, to individuals with stable liver function and no signs of liver failure.

Comparison of capillary and venous blood lactate and glucose values during cycle ergometry.

INTRODUCTION: The present study compared blood lactate and glucose values obtained from capillary and venous samples, and examined the utility of a modified capillary tube (55 mm in length) for a YSI 2300 Stat analyzer. METHODS: Sixteen subjects (17-26 yrs) completed a graded exercise test using a cycle ergometer. Blood samples were collected during the last minute of each three minute stage from an indwelling venous catheter and via finger puncture. All samples were analyzed for glucose and lactate using the YSI 2300 Stat analyzer (Yellow Springs Instruments, Yellow Springs, OH). RESULTS: Post hoc analysis indicated that venous blood lactate values were significantly lower than capillary values at 150 (p = 0.03) and 200 (p = 0.002) Watts. No differences were measured between the venous and capillary blood glucose values. CONCLUSIONS: Attempts should be made to quantify potential capillary and venous differences in blood lactate resulting from various experimental protocols and environments.

Metabolic responses to drafting during front crawl swimming.

We examined the metabolic responses to front crawl swimming when following directly behind (drafting) another swimmer. Seven trained male swimmers participated as subjects. VO2max (l.min-1) was measured during a progressive tethered swim test and was also estimated from a 20 s sample of expired air collected immediately after an all-out, 549 m (600 yard) swim. On different days, each subject performed two 549 m trials at 95% of his maximal swim velocity, one with drafting and one without drafting, using a counter-balanced design. Underwater pace lights were used to establish the predetermined swim velocity. Drafting significantly reduced post-exercise VO2 (2.85 +/- 0.63 vs 3.12 +/- 0.66 l.min-1), blood lactate (3.4 +/- 0.6 vs 5.0 +/- 0.5 mM), and rating of perceived exertion (11.7 +/- 0.4 vs 14.9 +/- 0.5) (P less than 0.05). A repeated measures ANOVA (condition X distance) also revealed significant reductions in HR during the 549 m swim (137.7 vs 146.8 beats.min-1) (P less than 0.05). The results indicate that drafting results in a decrease in energy expenditure for the range of speeds examined.